<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Neuromuscular Diseases</journal-id><journal-title-group><journal-title xml:lang="en">Neuromuscular Diseases</journal-title><trans-title-group xml:lang="ru"><trans-title>Нервно-мышечные болезни</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2222-8721</issn><issn publication-format="electronic">2413-0443</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">586</article-id><article-id pub-id-type="doi">10.17650/2222-8721-2024-14-1-10-24</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL REPORTS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Comparative multimodal sensory testing in multifocal motor neuropathy and multifocal variant of chronic inflammatory demyelinating polyradiculoneuropathy</article-title><trans-title-group xml:lang="ru"><trans-title>Сравнительное мультимодальное сенсорное тестирование при мультифокальной моторной нейропатии и мультифокальном варианте хронической воспалительной демиелинизирующей полирадикулонейропатии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9538-9690</contrib-id><name-alternatives><name xml:lang="en"><surname>Tumilovich</surname><given-names>T. A.</given-names></name><name xml:lang="ru"><surname>Тумилович</surname><given-names>Т. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Taisiya Aleksandrovna Tumilovich</p><p>80 Volokolamskoe Shosse, Моscow 125367</p></bio><bio xml:lang="ru"><p>Таисия Александровна Тумилович</p><p>125367 Москва, Волоколамское шоссе, 80</p></bio><email>tumilovich.taisiya@bk.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7924-3405</contrib-id><name-alternatives><name xml:lang="en"><surname>Grishina</surname><given-names>D. A.</given-names></name><name xml:lang="ru"><surname>Гришина</surname><given-names>Д. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>80 Volokolamskoe Shosse, Моscow 125367</p></bio><bio xml:lang="ru"><p>125367 Москва, Волоколамское шоссе, 80</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3956-6362</contrib-id><name-alternatives><name xml:lang="en"><surname>Suponeva</surname><given-names>N. A.</given-names></name><name xml:lang="ru"><surname>Супонева</surname><given-names>Н. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>80 Volokolamskoe Shosse, Моscow 125367</p></bio><bio xml:lang="ru"><p>125367 Москва, Волоколамское шоссе, 80</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9907-9393</contrib-id><name-alternatives><name xml:lang="en"><surname>Fedin</surname><given-names>P. A.</given-names></name><name xml:lang="ru"><surname>Федин</surname><given-names>П. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>80 Volokolamskoe Shosse, Моscow 125367</p></bio><bio xml:lang="ru"><p>125367 Москва, Волоколамское шоссе, 80</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Research Center of Neurology</institution></aff><aff><institution xml:lang="ru">ФГБНУ «Научный центр неврологии»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-03-01" publication-format="electronic"><day>01</day><month>03</month><year>2024</year></pub-date><volume>14</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>10</fpage><lpage>24</lpage><history><date date-type="received" iso-8601-date="2024-03-01"><day>01</day><month>03</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-03-01"><day>01</day><month>03</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Tumilovich T.A., Grishina D.A., Suponeva N.A., Fedin P.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Тумилович Т.А., Гришина Д.А., Супонева Н.А., Федин П.А.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Tumilovich T.A., Grishina D.A., Suponeva N.A., Fedin P.A.</copyright-holder><copyright-holder xml:lang="ru">Тумилович Т.А., Гришина Д.А., Супонева Н.А., Федин П.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://nmb.abvpress.ru/jour/article/view/586">https://nmb.abvpress.ru/jour/article/view/586</self-uri><abstract xml:lang="en"><p> </p><p><bold>Background.</bold> One of the key distinctions between multifocal motor neuropathy (MMN) and multifocal variant of chronic inflammatory demyelinating polyradiculoneuropathy (mCIDP) lies in the presence or absence of sensory deficits. Nevertheless, existing literature suggests that MMN can also involve sensory fibers of peripheral nerves, complicating the differential diagnosis of MMN and mCIDP, which remains a relevant issue.</p><p><bold>Aim.</bold> To evaluate the profile and intensity of objective sensory deficits and autonomic dysfunction in MMN and mCIDP, as well as to identify differential diagnostic markers.</p><p><bold>Materials and methods.</bold> Out of 65 patients followed up in the study, 30 were diagnosed with MMN and 35 were diagnosed with mCIDP. A retrospective analysis of clinical and epidemiological characteristics was carried out. The evaluation encompassed clinical assessments of sensory symptoms (including on the NTSS-9 scale), assessments of the severity of autonomic dysfunction using the COMPASS-31 questionnaire, and neurophysiological multimodal sensory testing (including electroneuromyography, computer pallesthesiometry, and short-latency auditory evoked potentials).</p><p><bold>Results.</bold> Patients with mCIDP were significantly more likely to have subjective (according to the NTSS-9 and COMPASS-31 scales) and objective (according to clinical examination) sensory deficits and autonomic dysfunction (<italic>p</italic> &lt;0.05). A third of patients with MMN reported sensory complaints, yet there was no objective evidence of impaired pain sensitivity. Changes in vibration sensitivity were equally prevalent during clinical assessment in both groups (<italic>p</italic> &gt;0.05). Electroneuromyography studies revealed significantly lower amplitudes of hand sensory nerve action potentials in the mCIDP group compared to MMN patients (<italic>p</italic> &lt;0.05). At the same time, a third of patients with MMN with a previous history of disease of 13 [10.0; 16.0] years also had low amplitudes of hand sensory nerve action potentials. The mean value of the autonomic reaction threshold, as well as the cutaneous vibration perception threshold were significantly higher in mCIDP compared to MMN (<italic>p</italic> &lt;0.05) when examining the hands.</p><p><bold>Conclusion.</bold> Differential diagnosis of MMN and mCIDP at the onset and in early disease (under 5 years) poses no challenges. However, it has been shown that a third of patients with MMN in the long-term catamnesis of the disease have some kind of sensory impairment, which may complicate the differential diagnosis with mCIDP. In such cases, employing computer pallesthesiography to measure vibration perception threshold can aid in clarifying the diagnosis and determining optimal treatment strategies.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение.</bold> Одним из принципиальных различий между мультифокальной моторной нейропатией (ММН) и мультифокальным вариантом хронической воспалительной демиелинизирующей полирадикулонейропатии (мХВДП) является наличие или отсутствие чувствительных нарушений. Тем не менее данные литературы свидетельствуют о том, что при ММН также возможно поражение сенсорных волокон периферических нервов. В связи с этим проблема дифференциальной диагностики ММН и мХВДП по-прежнему актуальна.</p><p><bold>Цель исследования</bold> – оценить спектр и тяжесть объективных сенсорных и автономных нарушений при ММН и мХВДП, определить дифференциально-диагностические маркеры.</p><p><bold>Материалы и методы.</bold> В исследование было включено 65 пациентов: 30 с диагнозом ММН и 35 с диагнозом мХВДП. Проведены ретроспективный анализ клинико-эпидемиологических характеристик, клиническая оценка сенсорных нарушений (в том числе по шкале NTSS-9), оценка тяжести вегетативных расстройств с помощью опросника COMPASS-31, нейрофизиологическое мультимодальное сенсорное тестирование (электронейромиография, компьютерная паллестезиометрия, коротколатентные слуховые вызванные потенциалы).</p><p><bold>Результаты.</bold> У пациентов с мХВДП достоверно чаще выявлялись субъективные (по данным шкалы NTSS-9 и опросника COMPASS-31) и объективные (по данным клинического осмотра) чувствительные и автономные нарушения (<italic>p</italic> &lt;0,05). Треть пациентов с ММН предъявляли сенсорные жалобы, однако объективного подтверждения нарушений болевой чувствительности обнаружено не было. При клинической оценке вибрационной чувствительности изменения выявлялись одинаково часто в обеих группах (<italic>p</italic> &gt;0,05). По данным электронейромиографии амплитуды потенциала действия сенсорных нервов рук в группе мХВДП оказались достоверно ниже, чем у больных с ММН (<italic>p</italic> &lt;0,05). В то же время у трети пациентов с ММН с катамнезом болезни 13 [10,0; 16,0] лет также регистрировались низкие амплитуды потенциала действия сенсорных нервов рук. Среднее значение порога вегетативной реакции, а также порог кожной вибрационной чувствительности при исследовании рук оказались значимо выше при мХВДП по сравнению с ММН (<italic>p</italic> &lt;0,05).</p><p><bold>Выводы.</bold> Дифференциальная диагностика ММН и мХВДП в дебюте и на ранних сроках болезни (до 5 лет) не вызывает затруднений. Однако показано, что треть пациентов с ММН в отдаленном катамнезе заболевания имеют те или иные сенсорные нарушения, что может затруднять дифференциальный диагноз ММН с мХВДП. В подобных случаях проведение компьютерной паллестезиографии с измерением порогового значения вибрационной чувствительности может помочь в уточнении диагноза и определении оптимальной тактики лечения.</p></trans-abstract><kwd-group xml:lang="en"><kwd>multifocal motor neuropathy</kwd><kwd>multifocal acquired demyelinating sensory and motor neuropathy</kwd><kwd>sensory deficits</kwd><kwd>sensory fibers</kwd><kwd>differential diagnosis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>мультифокальная моторная нейропатия, мультифокальный вариант хронической воспалительной демиелинизирующей полирадикулонейропатии, чувствительные нарушения, сенсорные волокна, дифференциальный диагноз</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Van den Bergh P.Y.K., van Doorn P.A., Hadden R.D.M. et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force – Second revision. J Peripher Nerv Syst 2021;26(3):242–68. DOI: 10.1111/jns.12455</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision. J Peripher Nerv Syst 2010;15(4):295–301. DOI: 10.1111/j.1529-8027.2010.00290.x</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Simon N.G., Kiernan M.C. Precise correlation between structural and electrophysiological disturbances in MADSAM neuropathy. Neuromuscul Disord 2015;25(11):904–7. DOI: 10.1016/j.nmd.2015.07.012</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Rajabally Y.A., Chavada G. Lewis–Sumner syndrome of pure upper-limb onset: Diagnostic, prognostic, and therapeutic features. Muscle Nerve 2009;39(2):206–20. DOI: 10.1002/mus.21199</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Fargeot G., Maisonobe T., Psimaras D. et al. Comparison of Lewis–Sumner syndrome with chronic inflammatory demyelinating polyradiculoneuropathy patients in a tertiary care centre. Eur J Neurol 2020;27(3):522–8. DOI:10.1111/ene.14101</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Lawson V.H., Arnold W.D. Multifocal motor neuropathy: A review of pathogenesis, diagnosis, and treatment. Neuropsychiatr Dis Treat 2014;567–76. DOI: 10.2147/NDT.S39592</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Delmont E., Benaïm Ch., Launay M. et al. Do patients having a decrease in SNAP amplitude during the course of MMN present with a different condition? J Neurol 2009;256(11):1876–80. DOI: 10.1007/s00415-009-5217-0</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Lambrecq V., Krim E., Rouanet-Larrivière M., Lagueny A. Sensory loss in multifocal motor neuropathy: A clinical and electrophysiological study. Muscle Nerve 2009;39(2):131–6. DOI: 10.1002/mus.21163</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Kimura, J. Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice. 4th edn. Oxford: Oxford University Press, 2013. 1176 p.</mixed-citation></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Gnezditskiy V.V., Korepina O.S. Atlas for evoked potentials of the brain (a practical guide based on the analysis of specific clinical observations). Ivanovo: Pres-Sto, 2011. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Гнездицкий В.В., Корепина О.С. Атлас по вызванным потенциалам мозга (практическое руководство, основанное на анализе конкретных клинических наблюдений). Иваново: Прес-Сто, 2011.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><mixed-citation>Cats E.A., Jacobs B.C., Yuki N. et al. Multifocal motor neuropathy: association of anti-GM1 IgM antibodies with clinical features. Neurology 2010;75(22):1961–7. DOI: 10.1212/WNL.0b013e3181ff94c2</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Abraham A., Albulaihe H., Alabdali M. et al. Elevated vibration perception thresholds in CIDP patients indicate more severe neuropathy and lower treatment response rates. PLoS One 2015;10(11):e0139689. DOI: 10.1371/journal.pone.0139689</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Harschnitz O., van den Berg L., Johansen L. et al. Autoantibody pathogenicity in a multifocal motor neuropathy induced pluripotent stem cell-derived model. Ann Neurol 2016; 80(1):71–88. DOI: 10.1002/ana.24680</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Collet R., Caballero-Ávila M., Querol L. Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies. Rev Neurol (Paris) 2023;179(8):831–43. DOI: 10.1016/j.neurol.2023.02.064</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Di Egidio M., Bacaglio C., Arrejoría R. et al. Evidence for spontaneous regulation of the humoral IgM anti-GM1 autoimmune response by IgG antibodies in multifocal motor neuropathy patients. J Peripher Nerv Syst 2023;28(3):398–406. DOI: 10.1111/jns.12583</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Ingall T.J., McLeod J.G., Tamura N. Autonomic function and unmyelinated fibers in chronic inflammatory demyelinating polyradiculonuropathy. Muscle Nerve 1990;13(1):70–6. DOI: 10.1002/mus.880130113</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Lyu R.K., Tang L.M., Wu Y.R., Chen S.T. Cardiovascular autonomic function and sympathetic skin response in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2002;26(5):669–72. DOI: 10.1002/mus.10251</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Stamboulis E., Katsaros N., Koutsis G. et al. Clinical and subclinical autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2006;33(1):78–84. DOI: 10.1002/mus.20438</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Figueroa J.J., Dyck P., Laughlin R. et al. Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 2012;78(10):702–8. DOI: 10.1212/WNL.0b013e3182494d66</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Rzepiński Ł., Emiliano Doneddu P., Cutellè C. et al. Autonomic nervous system involvement in chronic inflammatory demyelinating polyradiculoneuropathy: A literature review. Neurol Sci 2023;44(9):3071–82. DOI: 10.1007/s10072-023-06802-z</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Alessandro L., Pastor Rueda J.M., Wilken M. et al. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients. J Peripher Nerv Syst2018;23(3):154–8. DOI: 10.1111/jns.12266</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Dionne A., Nicolle M.W., Hahn A.F. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy. Muscle Nerve 2010;41(2):202–7. DOI: 10.1002/mus.21480</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Kerasnoudis A., Pitarokoili K., Behrendt V. et al. Bochum ultrasound score versus clinical and electrophysiological parameters in distinguishing acute-onset chronic from acute inflammatory demyelinating polyneuropathy. Muscle Nerve 2015;51(6):846–52. DOI: 10.1002/mus.24484</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Wadwekar V., Kalita J., Kant Misra U. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary? Neurol India 2011;59(5):664. DOI: 10.4103/0028-3886.86537</mixed-citation></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Grishina D.A., Suponeva N.A., Arestova A.S. et al. Chronic inflammatory demyelinating polyradiculoneuropathy overdiagnosis in Russia. Annaly klinicheskoy i eksperimentalnoy nevrologii = Annals of Clinical and Experimental Neurology 2023;17(3):5–12. (In Russ.). DOI: 10.54101/ACEN.2023.3.1</mixed-citation><mixed-citation xml:lang="ru">Гришина Д.А., Супонева Н.А., Арестова А.С. и др. Гипердиагностика хронической воспалительной демиелинизирующей полирадикулонейропатии в России. Анналы клинической и экспериментальной неврологии 2023;17(3):5–12. DOI: 10.54101/ACEN.2023.3.1</mixed-citation></citation-alternatives></ref></ref-list></back></article>
